Pasireotide: A new option for treatment of acromegaly
Acromegaly is characterized by excess production of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Although surgery is the first treatment option, somatostatin receptor analogs (SSRAs) can be used in selected cases which surgery is contraindicated. A patient who has been diagnosed as...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Society of Turaz Bilim
2020-06-01
|
| Serija: | Medicine Science |
| Teme: | |
| Online dostop: | http://www.ejmanager.com/fulltextpdf.php?mno=102548 |
| Oznake: |
Brez oznak, prvi označite!
|